跳至主要内容
临床试验/CTRI/2026/02/104121
CTRI/2026/02/104121尚未招募1/2 期

A RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF GAMBHARIYADI VATI IN THE MANAGEMENT OF LOWER URINARY TRACT INFECTION (LUTI) WITH SPECIAL REFERENCE TO MUTRAKRICHHA

Parul Institute Of Ayurved1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年3月5日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1

研究概览

简要总结

There is a growing burden of LUTIs and increasing antibiotic resistance

No comparative clinical evaluation has been performed to assess the efficacy of Gambhariyadi vati and Patalgarudi tablets in Mutrakrichha.

A comparative clinical trial will help in identifying the better formulation for LUTIs from an Ayurvedic perspective.

Ayurveda formulations not only address the symptoms but also aim to strengthen mutravaha srotas, offering both therapeutic and preventive outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients aged 18–70 years Clinical symptoms of LUTI (burning micturition, frequency, urgency, dysuria) Laboratory findings supporting LUTI (Urine routine and microscopic examination showing Willing to give informed written consent.

排除标准

  • Pyelonephritis chronic kidney disease having LUTI Pregnant and lactating women.
  • Patients with immunocompromised status (e.g., TB, chronic steroid use, chemotherapy).
  • Patients with chronic systemic illnesses such as: Uncontrolled Diabetes Mellitus, Uncontrolled Hypertension, Congestive Cardiac Failure.
  • Other Chronic Condition Having LUTI.

研究者

发起方
Parul Institute Of Ayurved
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Annpurna Chauhan

Parul Institute Of Ayurved

研究点 (1)

Loading locations...

相似试验